[Lower and lower cholesterol targets increase adverse effects].
Hjemdahl
Paul
P
Karolinska universitetssjukhuset, Solna. Paul.Hjemdahl@ki.se
Allhammar
Anette
A
Heaton
Claire
C
Hulting
Johan
J
Kahan
Thomas
T
Malmström
Rickard
R
Martinsson
Arne
A
Rücker
Franz
F
Schenck-Gustafsson
Karin
K
Schwieler
Jonas
J
Törnerud
Mattias
M
Wettermark
Björn
B
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008078:Cholesterol, LDL / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced; D012206:Rhabdomyolysis / Q000139:chemically induced; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage / Q000009:adverse effects*
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019821:Simvastatin